Details

Autor(en) / Beteiligte

• Li, Wenjun
• Feng, Guoshuai
• Gauthier, Jason M
• Lokshina, Inessa
• Higashikubo, Ryuji
• Evans, Sarah
• Liu, Xinping
• Hassan, Adil
• Tanaka, Satona
• Cicka, Markus
• Hsiao, Hsi-Min
• Ruiz-Perez, Daniel
• Bredemeyer, Andrea
• Gross, Richard W
• Mann, Douglas L
• Tyurina, Yulia Y
• Gelman, Andrew E
• Kagan, Valerian E
• Linkermann, Andreas
• Lavine, Kory J
• Kreisel, Daniel

Titel

Ferroptotic cell death and TLR4/Trif signaling initiate neutrophil recruitment after heart transplantation

Ist Teil von

• The Journal of clinical investigation, 2019-06, Vol.129 (6), p.2293-2304

Ort / Verlag

United States: American Society for Clinical Investigation

Erscheinungsjahr

2019

Quelle

MEDLINE

Beschreibungen/Notizen

• Non-apoptotic forms of cell death can trigger sterile inflammation through the release of danger-associated molecular patterns, which are recognized by innate immune receptors. However, despite years of investigation the mechanisms which initiate inflammatory responses after heart transplantation remain elusive. Here, we demonstrate that ferrostatin-1 (Fer-1), a specific inhibitor of ferroptosis, decreases the level of pro-ferroptotic hydroperoxy-arachidonoyl-phosphatidylethanolamine, reduces cardiomyocyte cell death and blocks neutrophil recruitment following heart transplantation. Inhibition of necroptosis had no effect on neutrophil trafficking in cardiac grafts. We extend these observations to a model of coronary artery ligation-induced myocardial ischemia reperfusion injury where inhibition of ferroptosis resulted in reduced infarct size, improved left ventricular systolic function, and reduced left ventricular remodeling. Using intravital imaging of cardiac transplants, we uncover that ferroptosis orchestrates neutrophil recruitment to injured myocardium by promoting adhesion of neutrophils to coronary vascular endothelial cells through a TLR4/TRIF/type I IFN signaling pathway. Thus, we have discovered that inflammatory responses after cardiac transplantation are initiated through ferroptotic cell death and TLR4/Trif-dependent signaling in graft endothelial cells. These findings provide a platform for the development of therapeutic strategies for heart transplant recipients and patients, who are vulnerable to ischemia reperfusion injury following restoration of coronary blood flow.